TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 6973988

Group type: EXPERIMENTAL
Intervention: Fluproquazone 200 mg
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Pentazocine 50 mg
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Fluproquazone 100 mg
Number of subjects: 138

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138
Study: 31166961

Group type: EXPERIMENTAL
Intervention: Ticlopidine/Ginkgo biloba extract combination drug (Yuclid)
Number of subjects: 4831
Study: 28368352

Group type: EXPERIMENTAL
Intervention: Oral melatonin (3 mg, group M) twice daily
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo (group P)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Oral melatonin (3 mg, group M)
Number of subjects: 64
Study: 26186658

Group type: EXPERIMENTAL
Intervention: Roxithromycin in crushed tablet form (n=10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Roxithromycin in conventional tablet form (n=10)
Number of subjects: 20
Study: 24222666

Group type: EXPERIMENTAL
Intervention: Definite PAD (ABI <0.90)
Number of subjects: 1566

Group type: EXPERIMENTAL
Intervention: Borderline PAD (ABI 0.90 to 0.99)
Number of subjects: 1566

Group type: EXPERIMENTAL
Intervention: Low normal ABI (ABI 1.00 to 1.09)
Number of subjects: 1566

Group type: EXPERIMENTAL
Intervention: No PAD (ABI 1.10 to 1.40)
Number of subjects: 1566

Group type: EXPERIMENTAL
Intervention: Asymptomatic participants with PAD
Number of subjects: 1566
Study: 21951682

Group type: EXPERIMENTAL
Intervention: Bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide (VMPT-VT)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Bortezomib-melphalan-prednisone (VMP)
Number of subjects: 140
Study: 18504393

Group type: EXPERIMENTAL
Intervention: rhGH (0.058 IU.kg(‐1).day(‐1))
Number of subjects: 48
Study: 17140161

Group type: EXPERIMENTAL
Intervention: Iodixanol (iso-osmolar contrast media)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Iopromid (low-osmolar contrast media)
Number of subjects: 221
Study: 14502378

Group type: EXPERIMENTAL
Intervention: Rubber band ligation
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Infrared coagulation
Number of subjects: 100
Study: 10732318

Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Metoclopramide 5 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Domperidone 10 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Metoclopramide 10 mg, Metoclopramide 5 mg, Domperidone 10 mg
Number of subjects: 10
Study: 8615482

Group type: EXPERIMENTAL
Intervention: Hemodilution (6 and 12 mL/kg isovolemic exchange of blood for 6% hydroxyethyl starch)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Hemodilution
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study: 1486544

Group type: EXPERIMENTAL
Intervention: Heart rate control achieved by verapamil
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Cardioversion to normal sinus rhythm
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Post cardioversion
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Follow-up after cardioversion
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Left atrial size measurement
Number of subjects: 18
Study: 6539363

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metoclopramide
Number of subjects: 0
Study: 29671255

Group type: EXPERIMENTAL
Intervention: Topical Diquafosol Tetrasodium (3% DQS)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Artificial Tear (preservative-free AT)
Number of subjects: 27
Study: 26777769

Group type: EXPERIMENTAL
Intervention: DGG + Ozone Therapy (OT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: DGG alone (Control)
Number of subjects: 30
Study: 24525659

Group type: EXPERIMENTAL
Intervention: AZD2624 40 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Olanzapine 15 mg
Number of subjects: 0
Study: 23190222

Group type: EXPERIMENTAL
Intervention: lopinavir-ritonavir-based ART
Number of subjects: 176

Group type: COMPARATOR
Intervention: NNRTI-based ART
Number of subjects: 176
Study: 20187284

Group type: EXPERIMENTAL
Intervention: Carbohydrate-protein-leucine drink after resistance exercise (B)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Fasted state (F)
Number of subjects: 6
Study: 18165639

Group type: EXPERIMENTAL
Intervention: Taxane-based combinations with anthracycline
Number of subjects: 22903
Study: 15624096

Group type: EXPERIMENTAL
Intervention: Pioglitazone (3 weeks treatment)
Number of subjects: 10
Study: 14568853

Group type: EXPERIMENTAL
Intervention: High-volume hospitals
Number of subjects: 3161

Group type: COMPARATOR
Intervention: Low-volume hospitals
Number of subjects: 3161
Study: 11871816

Group type: COMPARATOR
Intervention: Open hemorrhoidectomy
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Semi-closed hemorrhoidectomy
Number of subjects: 34
Study: 10399998

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 2245
Study: 7583806

Group type: EXPERIMENTAL
Intervention: Subcutaneous infusion (SC) of 1000 mL of 5% glucose solution containing 4 g NaCl over 6 hours
Number of subjects: 6

Group type: COMPARATOR
Intervention: Intravenous infusion (IV) of 1000 mL of 5% glucose solution containing 4 g NaCl over 6 hours
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Both SC and IV infusions
Number of subjects: 6
Study: 2179286

Group type: EXPERIMENTAL
Intervention: Metoprolol (100 mg od)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Atenolol (50 mg od)
Number of subjects: 83
Study: 7023743

Group type: EXPERIMENTAL
Intervention: Randomized controlled clinical trial
Number of subjects: 0

Group type: COMPARATOR
Intervention: Withdrawal of patients due to ineligibility, lack of compliance, or poor data quality
Number of subjects: 0
Study: 30944359

Group type: EXPERIMENTAL
Intervention: Balanced Index (BI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group Performance Index (GPI)
Number of subjects: 0
Study: 28183303

Group type: EXPERIMENTAL
Intervention: Anti-stigma-targeted lecture
Number of subjects: 834

Group type: COMPARATOR
Intervention: Non-targeted lecture
Number of subjects: 834
Study: 25918756

Group type: EXPERIMENTAL
Intervention: Separator placement
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Initial arch wire ligation (0.016 NiTi)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: T‐loop activation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Banding
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Intermaxillary elastics
Number of subjects: 100
Study: 23817160

Group type: EXPERIMENTAL
Intervention: Dynamic psychotherapy
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Psychoanalysis
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 8

Group type: COMPARATOR
Intervention: Clinical management
Number of subjects: 8
Study: 21112682

Group type: EXPERIMENTAL
Intervention: Internet peer support via a listserv
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Internet peer support via a bulletin board
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 300
Study: 19579197

Group type: EXPERIMENTAL
Intervention: Albumin polymer instillation (Bioglue Cryolife, Inc.) during surgery
Number of subjects: 68

Group type: COMPARATOR
Intervention: Non-polymer treatment during surgery
Number of subjects: 68

Group type: COMPARATOR
Intervention: Non-polymer treatment
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Polymer treatment
Number of subjects: 68
Study: 17446407

Group type: EXPERIMENTAL
Intervention: Isometric resistance training of the plantar flexor muscles (12 sessions over 4 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study: 15262187

Group type: EXPERIMENTAL
Intervention: Simvastatin (40 mg per day)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Simvastatin (1 microM in vitro)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Prenyl transferase inhibitors (in vitro)
Number of subjects: 13
Study: 11254825

Group type: EXPERIMENTAL
Intervention: 30 mg intravenous pamidronate every 3 months + 1 g calcium daily
Number of subjects: 28

Group type: COMPARATOR
Intervention: 1 g calcium daily
Number of subjects: 28
Study: 9567053

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy for the prevention of recurrence of unipolar affective disorders
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8313786

Group type: EXPERIMENTAL
Intervention: Cisplatin intrahepatic arterial infusion (24 mg/m2/day, bolus) plus systemic intravenous 5-fluorouracil (250, 375, or 500 mg/m2/day)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Cisplatin continuous infusion (24 mg/m2/day) plus systemic intravenous 5-fluorouracil (250, 375, or 500 mg/m2/day)
Number of subjects: 109
Study: 3049338

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 50 mg/day
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 100 mg/day
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 200 mg/day
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (varied doses)
Number of subjects: 343
Study: 28971569

Group type: EXPERIMENTAL
Intervention: Manual toothbrush alone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Manual toothbrush plus dental floss
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Manual toothbrush plus interdental brushes
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Manual toothbrush plus rubber interdental picks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (manual toothbrush only)
Number of subjects: 60
Study: 27470295

Group type: EXPERIMENTAL
Intervention: Fat grafting
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 18
Study: 24957823

Group type: EXPERIMENTAL
Intervention: PA-824 with efavirenz
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: PA-824 with lopinavir-ritonavir
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: PA-824 with rifampin
Number of subjects: 52

Group type: COMPARATOR
Intervention: PA-824 alone
Number of subjects: 52
Study: 21853390

Group type: EXPERIMENTAL
Intervention: Fibrin sealant (FS) fixation (TISSEEL)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Staple mesh fixation (ST) (EMS Stapler)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Both FS and ST groups
Number of subjects: 89
Study: 19834809

Group type: EXPERIMENTAL
Intervention: Computed virtual chromoendoscopy (CVC) mode colonoscopy
Number of subjects: 128

Group type: COMPARATOR
Intervention: Conventional white-light colonoscopy
Number of subjects: 128
Study: 18296027

Group type: EXPERIMENTAL
Intervention: 40 mg of methylprednisolone injected into the masseter muscle
Number of subjects: 35

Group type: COMPARATOR
Intervention: No intramuscular corticoid (control group)
Number of subjects: 35
Study: 15702708

Group type: EXPERIMENTAL
Intervention: Laser Doppler flowmetry (LDF)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 69
Study: 15352598

Group type: EXPERIMENTAL
Intervention: Stereotactic evacuation of the hematoma
Number of subjects: 242

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 242
Study: 11113722

Group type: EXPERIMENTAL
Intervention: Valsartan titrated to 160 mg b.i.d.
Number of subjects: 5010

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5010
Study: 9196156

Group type: EXPERIMENTAL
Intervention: gemcitabine 1,000 mg/m2 weekly x 7 followed by 1 week of rest, then weekly x 3 every 4 weeks thereafter
Number of subjects: 126

Group type: COMPARATOR
Intervention: fluorouracil (5‐FU) 600 mg/m2 once weekly
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: gemcitabine
Number of subjects: 126

Group type: COMPARATOR
Intervention: 5‐FU
Number of subjects: 126
Study: 7505354

Group type: EXPERIMENTAL
Intervention: Pinacidil (25 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Quinidine (330 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 3987800

Group type: EXPERIMENTAL
Intervention: i.v. infusions of adriamycin (short: 3.00 min)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: i.v. infusions of adriamycin (prolonged: 45 min‐16 h)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: i.v. infusions of adriamycin
Number of subjects: 21
Study: 3277903

Group type: EXPERIMENTAL
Intervention: Natural progesterone, 100 mg 2 times daily
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Tamoxifen, 10 mg 2 times daily
Number of subjects: 33

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 33
Study: 31799996

Group type: EXPERIMENTAL
Intervention: Brimonidine gel, 0.33%
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 20
Study: 31238715

Group type: EXPERIMENTAL
Intervention: Maternal pre-pregnancy body mass index increase
Number of subjects: 587

Group type: EXPERIMENTAL
Intervention: Maternal pre-pregnancy body mass index
Number of subjects: 587

Group type: EXPERIMENTAL
Intervention: Paternal pre-pregnancy body mass index
Number of subjects: 587
Study: 28639366

Group type: EXPERIMENTAL
Intervention: Real-time video feedback of their own back during massage treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Watching a neutral object (control)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Video of another person of the same sex being massaged (control)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Picture of the own back (control)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Keeping one's eyes closed (control)
Number of subjects: 20
Study: 25800891

Group type: EXPERIMENTAL
Intervention: Vorinostat 300 mg twice daily on specified days of a 21-day cycle
Number of subjects: 661

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 661

Group type: EXPERIMENTAL
Intervention: Vorinostat
Number of subjects: 661
Study: 23467941

Group type: EXPERIMENTAL
Intervention: Cisatracurium
Number of subjects: 100

Group type: COMPARATOR
Intervention: Atracurium
Number of subjects: 100
Study: 22282574

Group type: EXPERIMENTAL
Intervention: Health education intervention on compliance with road safety signs
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 200
Study: 20129545

Group type: EXPERIMENTAL
Intervention: XIENCE V everolimus-eluting stent (EES)
Number of subjects: 300

Group type: COMPARATOR
Intervention: TAXUS paclitaxel-eluting stent (PES)
Number of subjects: 300
Study: 17075501

Group type: EXPERIMENTAL
Intervention: Nutrilarm capsules, twice a day for 6 months
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo capsules, twice a day for 6 months
Number of subjects: 71
Study: 11894595

Group type: EXPERIMENTAL
Intervention: Endovascular stent-graft implantation
Number of subjects: 26
Study: 10414072

Group type: EXPERIMENTAL
Intervention: Modified URS LAR VII with LMA
Number of subjects: 14

Group type: COMPARATOR
Intervention: AMBU bag
Number of subjects: 14
Study: 7750023

Group type: EXPERIMENTAL
Intervention: Sustained-release formulation B
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sustained-release formulation C
Number of subjects: 12

Group type: COMPARATOR
Intervention: Nonsustained-release reference preparation A
Number of subjects: 12
Study: 2105675

Group type: EXPERIMENTAL
Intervention: Fenoterol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Fenoterol + Sodium cromoglycate
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sodium cromoglycate
Number of subjects: 20
Study: 6107768

Group type: EXPERIMENTAL
Intervention: IGIV‐maltose (5% solution in 10% maltose)
Number of subjects: 29

Group type: COMPARATOR
Intervention: IGIV (maltose-free immune globulin)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: IGIV‐maltose
Number of subjects: 29
Study: 29885661

Group type: EXPERIMENTAL
Intervention: Time-to-event (TTE) display
Number of subjects: 353

Group type: EXPERIMENTAL
Intervention: Emoticons
Number of subjects: 353

Group type: EXPERIMENTAL
Intervention: Bar chart
Number of subjects: 353
Study: 27491607

Group type: EXPERIMENTAL
Intervention: Intramyocardial CD34(+) cell administration
Number of subjects: 112

Group type: COMPARATOR
Intervention: Open-label standard of care
Number of subjects: 112

Group type: COMPARATOR
Intervention: Active control (IM placebo injections)
Number of subjects: 112
Study: 26537273

Group type: EXPERIMENTAL
Intervention: Calcium Citrate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium Carbonate
Number of subjects: 0
Study: 23807323

Group type: EXPERIMENTAL
Intervention: Pemetrexed (500 mg/m2)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Docetaxel (60 mg/m2)
Number of subjects: 85
Study: 20069285

Group type: EXPERIMENTAL
Intervention: Integrated feedback using Lissajous plots
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition without integrated feedback
Number of subjects: 0
Study: 18361983

Group type: EXPERIMENTAL
Intervention: AF‐1 (UY) blue‐light‐filtering intraocular lens
Number of subjects: 0

Group type: COMPARATOR
Intervention: AF‐1 (UV) intraocular lens
Number of subjects: 0
Study: 17149987

Group type: EXPERIMENTAL
Intervention: Plyometric training (PLY; n = 7) - 3 x 30 minutes sessions per week for 9 weeks
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (CON; n = 8)
Number of subjects: 15
Study: 15259924

Group type: EXPERIMENTAL
Intervention: TENS therapy for 20 minutes
Number of subjects: 20

Group type: COMPARATOR
Intervention: No TENS therapy (control group)
Number of subjects: 20
Study: 10904661

Group type: EXPERIMENTAL
Intervention: Antibiotics for three days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antibiotics without examination of the urine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment by telephone for women with earlier episodes of UTI
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo-controlled trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Negative dipstick test
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dysuria or frequency
Number of subjects: 0
Study: 9273209

Group type: EXPERIMENTAL
Intervention: Subcutaneous Epo (2000 U, twice weekly)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Intravenous Epo (156 +/- 57 U/kg/week to 205 +/- 105 U/kg/week, thrice weekly)
Number of subjects: 19
Study: 2059819

Group type: EXPERIMENTAL
Intervention: Ultrasonography
Number of subjects: 10
Study: 6354441

Group type: EXPERIMENTAL
Intervention: Sequential administration of ifosfamide (with mesna), methotrexate (or 5-FU), and vinblastine (protocol I)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Combined administration of adriamycin and vincristine (protocol II)
Number of subjects: 29
Study: 31909561

Group type: EXPERIMENTAL
Intervention: FE NO measurements with initial FE NO <50 ppb
Number of subjects: 1112

Group type: EXPERIMENTAL
Intervention: FE NO measurements with initial FE NO ≥50 ppb
Number of subjects: 1112

Group type: EXPERIMENTAL
Intervention: FE NO measurements over a 3-month period
Number of subjects: 1112
Study: 30418217

Group type: COMPARATOR
Intervention: Balanced hydroxyethyl starch solution (colloid)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Balanced crystalloid solution (crystalloid)
Number of subjects: 160
Study: 30618445

Group type: EXPERIMENTAL
Intervention: Three-dose sulphadoxine-pyrimethamine (SP)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Two-dose sulphadoxine-pyrimethamine (SP)
Number of subjects: 210
Study: 26518245

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 140

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 140
Study: 25268398

Group type: EXPERIMENTAL
Intervention: Multiple-injection technique (group M)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Single-injection technique (group S)
Number of subjects: 90
Study: 21669958

Group type: EXPERIMENTAL
Intervention: Cell phone intervention (CPI)
Number of subjects: 474

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 474
Study: 20534327

Group type: EXPERIMENTAL
Intervention: Masticated rice with varying particle sizes
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Masticated rice with particles smaller than 500 microm
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Masticated rice with particles greater than 2000 microm
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: In vitro digestion of rice
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Overall habitual mastication
Number of subjects: 15
Study: 18171953

Group type: EXPERIMENTAL
Intervention: External fixation combined with percutaneous pin fixation
Number of subjects: 137

Group type: COMPARATOR
Intervention: Plate fixation
Number of subjects: 137
Study: 15763607

Group type: EXPERIMENTAL
Intervention: Lumiracoxib 100 mg QD
Number of subjects: 1551

Group type: EXPERIMENTAL
Intervention: Lumiracoxib 100 mg QD with loading dose
Number of subjects: 1551

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg QD
Number of subjects: 1551

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1551
Study: 12686794

Group type: EXPERIMENTAL
Intervention: Dysport 500 units
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Dysport 1,000 units
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Dysport 1,500 units
Number of subjects: 234

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 234
Study: 9892252

Group type: EXPERIMENTAL
Intervention: D-cycloserine, 50 mg/d
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 9160649

Group type: EXPERIMENTAL
Intervention: Trimipramine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 20
Study: 1425861

Group type: EXPERIMENTAL
Intervention: Intensified oral nutrition with nutrition education, daily dietician visits, and food intake records.
Number of subjects: 29

Group type: COMPARATOR
Intervention: Ad libitum nutritional intake during the whole tumour therapy.
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Intensified oral nutrition.
Number of subjects: 29

Group type: COMPARATOR
Intervention: Ad libitum nutritional intake.
Number of subjects: 29
Study: 6721407

Group type: EXPERIMENTAL
Intervention: Small (2.5 mm) Redivac drain
Number of subjects: 50

Group type: COMPARATOR
Intervention: Large (6 mm) Redivac drain
Number of subjects: 50
Study: 31798895

Group type: EXPERIMENTAL
Intervention: Motivational interviewing to improve adherence to healthy eating in addition to routine care
Number of subjects: 189

Group type: COMPARATOR
Intervention: Routine care only (reference cohort)
Number of subjects: 189
Study: 30200800

Group type: EXPERIMENTAL
Intervention: YAG laser vitreolysis
Number of subjects: 30